Ultromics raised €48M in a Series C round in Jul 2025. The company is based in Oxford, UK. Investors in the round: Allegis Capital, Blue Venture Fund, GV and 6 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
